trending Market Intelligence /marketintelligence/en/news-insights/trending/pl6gtattyfld7rd-saep3w2 content esgSubNav
Log in to other products


Looking for more?

Contact Us
In This List

GeoVax names CEO


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Climate Credit Analytics: Linking climate scenarios to financial impacts


Global M&A Infographic Q1 2021


Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

GeoVax names CEO

Smyrna, Ga.-based GeoVax Labs Inc., a clinical-stage biotechnology company, appointed David Dodd as president and CEO, effective Sept. 1.

Dodd succeeds Robert McNally, who has retired but will remain a director of the company.

Dodd became a board member of the company in March 2010 and was elected chairman in January 2011. He served as CEO and director of Medizone International Inc., a medical device manufacturer, from September 2017 to June 2018.